These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13969823)

  • 1. [General mechanism of action and side-effects of antiblastic chemotherapy].
    BASERGA A
    Arcisp S Anna Ferrara; 1963; 16():171-5. PubMed ID: 13969823
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of preparations increasing the antiblastic action of antitumor substances on the results of postoperative chemotherapy in lung cancer].
    Mantsurov NE
    Vrach Delo; 1982 Apr; (4):88-91. PubMed ID: 6285619
    [No Abstract]   [Full Text] [Related]  

  • 3. [The biochemical mechanism of the antiblastic action of cytostatic drugs].
    Zimel H
    Stud Cercet Endocrinol; 1967; 18(4):369-71. PubMed ID: 6082522
    [No Abstract]   [Full Text] [Related]  

  • 4. [SURGERY AND ANTIBLASTIC CHEMOTHERAPY IN TREATMENT OF MALIGNANTNEOPLASMS].
    MALAN E
    Minerva Med; 1965 Jun; 56():1968-75. PubMed ID: 14325054
    [No Abstract]   [Full Text] [Related]  

  • 5. [FUNDAMENTAL PRINCIPLES OF ANTIBLASTIC CHEMOTHERAPY].
    ESTEVEZ RA
    Sem Med; 1964 Mar; 124():399-401. PubMed ID: 14153138
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANTIBLASTIC CHEMOTHERAPY OF LUNG CANCER. COLLECTIVE REVIEW].
    SCOCCIA S
    G Ital Chemioter; 1964; 11():119-29. PubMed ID: 14279686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiblastic chemotherapy in gynecological oncology].
    Macchioni B; Poggio A; Tanferna M
    Minerva Ginecol; 1968 Dec; 20(24):1985-93. PubMed ID: 5736215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Asymptomatic electrocardiographic abnormalities during antiblastic chemotherapy].
    Bottoni P; Bobba L; Ranieri MG; Croce M; Zaietta P; Provera F
    Minerva Med; 1983 Oct; 74(38):2211-8. PubMed ID: 6196689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiblastic chemotherapy].
    ESTEVEZ RA
    Rev Sanid Milit Argent; 1957; 56(4):349-74. PubMed ID: 13579628
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiblastic (antileukemic) action of thiodipin in experimental conditions].
    CHERNOV VA; GRUSHINA AA
    Probl Gematol Pereliv Krovi; 1962 Feb; 7():3-8. PubMed ID: 13878760
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiblastic chemotherapy in the treatment of cancer of the prostate].
    Pavone-Macaluso M; Caramia G; Vecchioni M
    J Urol Nephrol (Paris); 1972; 78(7):621-34. PubMed ID: 4675962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiblastic chemotherapy in gynecologic oncology].
    Vaglio N
    Arch Ostet Ginecol; 1969; 74(2):93-132. PubMed ID: 5406259
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lysozyme in antiblastic chemotherapy in gynecology].
    STRINGA L; BRUSOTTI A
    Quad Clin Ostet Ginecol; 1961 Oct; 16():751-6. PubMed ID: 13917801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experience with the use of ranitidine in the prevention of gastroduodenal damage caused by antiblastic polychemotherapy].
    D'Agata A
    Minerva Med; 1998 Oct; 89(10):359-63. PubMed ID: 10189899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiblastic chemotherapy and its oral manifestations (I)].
    Salvato A; Tassarotti B; Antonucci F
    Riv Ital Stomatol; 1982; 51(5):433-9. PubMed ID: 6962982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiemetic and antinauseant effect of alizapride in patients subjected to antiblastic infusion chemotherapy in a day-hospital regime].
    Cicchetti F; Viganò P; Borghi CM; Franzini A; Alfano G; Antolini C
    G Ital Oncol; 1989; 9(1):18-21. PubMed ID: 2707835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiblastic chemotherapy in urology].
    Furnari S; Pavone-Macaluso S; Veroux G; Mattea E
    Minerva Urol; 1971; 23(2):87-9. PubMed ID: 5105988
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current and prospective role of antiblastic chemotherapy in gynecologic oncology].
    Macchioni B; Trompeo P
    Minerva Ginecol; 1968 Feb; 20(3):272-81. PubMed ID: 4190616
    [No Abstract]   [Full Text] [Related]  

  • 19. [Decrease of hematic bradykininogen during antiblastic chemotherapy].
    Gasparri F; Periti P; Maijnelli M
    Boll Soc Ital Biol Sper; 1965 May; 41(10):494-6. PubMed ID: 5875586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiblastic chemotherapy and its oral manifestations (III)].
    Salvato A; Tassarotti B; Antonucci F
    Riv Ital Stomatol; 1982; 51(10):837-43. PubMed ID: 6962975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.